183 related articles for article (PubMed ID: 10426790)
21. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon.
Karakiulakis G; Papanikolaou C; Jankovic SM; Aletras A; Papakonstantinou E; Vretou E; Mirtsou-Fidani V
Invasion Metastasis; 1997; 17(3):158-68. PubMed ID: 9702942
[TBL] [Abstract][Full Text] [Related]
22. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
Wylie S; MacDonald IC; Varghese HJ; Schmidt EE; Morris VL; Groom AC; Chambers AF
Clin Exp Metastasis; 1999 Mar; 17(2):111-7. PubMed ID: 10411102
[TBL] [Abstract][Full Text] [Related]
23. [Effects of HGF on the production of matrix metalloproteinases by colonic cancer cells DHD/K12].
Aparicio T; Kermorgant S; Lewin MJ; Lehy T
C R Seances Soc Biol Fil; 1998; 192(2):311-5. PubMed ID: 9759374
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice.
Wang X; Fu X; Brown PD; Crimmin MJ; Hoffman RM
Cancer Res; 1994 Sep; 54(17):4726-8. PubMed ID: 8062271
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
Zervos EE; Norman JG; Gower WR; Franz MG; Rosemurgy AS
J Surg Res; 1997 May; 69(2):367-71. PubMed ID: 9224409
[TBL] [Abstract][Full Text] [Related]
26. Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.
Nabeshima K; Inoue T; Shimao Y; Okada Y; Itoh Y; Seiki M; Koono M
Cancer Res; 2000 Jul; 60(13):3364-9. PubMed ID: 10910039
[TBL] [Abstract][Full Text] [Related]
27. Rat amnion type IV collagen composition and metabolism: implications for membrane breakdown.
Lei H; Kalluri R; Furth EE; Baker AH; Strauss JF
Biol Reprod; 1999 Jan; 60(1):176-82. PubMed ID: 9858503
[TBL] [Abstract][Full Text] [Related]
28. Differing effects of endogenous and synthetic inhibitors of metalloproteinases on intestinal tumorigenesis.
Goss KJ; Brown PD; Matrisian LM
Int J Cancer; 1998 Nov; 78(5):629-35. PubMed ID: 9808534
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro.
Zervos EE; Shafii AE; Haq M; Rosemurgy AS
J Surg Res; 1999 Jun; 84(2):162-7. PubMed ID: 10357914
[TBL] [Abstract][Full Text] [Related]
30. Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis.
Pollitt CC; Pass MA; Pollitt S
Equine Vet J Suppl; 1998 Sep; (26):119-24. PubMed ID: 9932102
[TBL] [Abstract][Full Text] [Related]
31. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
[TBL] [Abstract][Full Text] [Related]
32. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
[TBL] [Abstract][Full Text] [Related]
33. Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury.
Falk V; Soccal PM; Grünenfelder J; Hoyt G; Walther T; Robbins RC
Eur J Cardiothorac Surg; 2002 Jul; 22(1):53-8. PubMed ID: 12103373
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.
Chirivi RG; Garofalo A; Crimmin MJ; Bawden LJ; Stoppacciaro A; Brown PD; Giavazzi R
Int J Cancer; 1994 Aug; 58(3):460-4. PubMed ID: 8050828
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Corbel M; Caulet-Maugendre S; Germain N; Molet S; Lagente V; Boichot E
J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
[TBL] [Abstract][Full Text] [Related]
37. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts.
Davies B; Brown PD; East N; Crimmin MJ; Balkwill FR
Cancer Res; 1993 May; 53(9):2087-91. PubMed ID: 8347186
[TBL] [Abstract][Full Text] [Related]
38. Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.
Das A; McLamore A; Song W; McGuire PG
Arch Ophthalmol; 1999 Apr; 117(4):498-503. PubMed ID: 10206578
[TBL] [Abstract][Full Text] [Related]
39. Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases.
Kelly T; Yan Y; Osborne RL; Athota AB; Rozypal TL; Colclasure JC; Chu WS
Clin Exp Metastasis; 1998 Aug; 16(6):501-12. PubMed ID: 9872598
[TBL] [Abstract][Full Text] [Related]
40. Induction of matrix metalloproteinases and collagenolysis in chick embryonic membranes before hatching.
Lei H; Furth EE; Kalluri R; Wakenell P; Kallen CB; Jeffrey JJ; Leboy PS; Strauss JF
Biol Reprod; 1999 Jan; 60(1):183-9. PubMed ID: 9858504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
